Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
LifeSci Communications Promotes Ian Stone to Chief Executive Officer
LifeSci Communications announced the promotion of Ian Stone to chief executive officer to guide the company’s growth and strengthen its partnerships with healthcare innovators.
Stone joined LifeSci Communications as president in January 2025, overseeing the 40-person team, daily operations and client strategy. He will be based in LifeSci’s new and growing San Diego Office alongside teams from LifeSci Consulting and LifeSci Advisors.
Jackson Choy Joins Match Health as Co-Founder, Pulse President
Match Health Collective announced the launch of Pulse Health Sciences, a new medical education and insights division co-founded by Jackson Choy, who will serve as President. Pulse delivers high-quality, evidence-based, peer-to-peer education designed to help clinicians make better-informed decisions and improve patient outcomes.
Leona Health Launches First AI Doctor Co-Pilot on WhatsApp
Leona Health – the world’s first AI co-pilot for doctors built on WhatsApp – announced its launch across 14 countries and 22 specialties. Backed by $14M in seed funding, led by Andreessen Horowitz (a16z), with participation from General Catalyst (pre-seed lead), Accel, Maven Clinic’s Kate Ryder, Nubank’s David Vélez, and Rappi’s Simón Borrero, Leona Health is partnering with physicians to build smarter AI-powered support.
Bioptimus Launches M-Optimus to Transform Biological AI
Bioptimus, a leading company in artificial intelligence for biology, has announced a significant advancement with the launch of M-Optimus, the first AI model designed to integrate multiple biological data types and simulate complex biological systems. The company is providing early access to a select group of pioneer clients while also enhancing availability of its top-rated pathology model, H-Optimus-1, through a special program in partnership with Amazon SageMaker AI. Until now, most AI models and biological research have focused on a single data type, such as genetic sequences or medical imaging, which has limited the understanding and application of biology in healthcare. Bioptimus envisions M-Optimus as a universal framework that can model cells, tissues, and patients across diverse diseases and populations, providing a comprehensive view of biology that can accelerate research and improve patient outcomes. The first version of M-Optimus combines hematoxylin and eosin stained histology images, bulk RNA sequencing, spatial transcriptomics, and clinical data into a single model. This is the first AI model in the world to merge multiple biological modalities at this scale and it was trained on one of the largest proprietary datasets, covering millions of patients, more than 50 organ types, and hundreds of medical centers. M-Optimus can accelerate drug discovery and clinical trial design by predicting patient response, helping pharmaceutical companies identify the most promising drug candidates and suitable patients, potentially saving years and millions of dollars.
Norgine Expands Liver and Specialty Portfolio With Vir Biotechnology In-Licensing Agreement
Norgine, a leading European specialty pharmaceutical company, announced an exclusive licensing agreement under which Norgine will commercialise the combination of tobevibart and elebsiran for the treatment of chronic hepatitis delta (CHD) in Europe, Australia and New Zealand following the necessary marketing authorisations. There is a high unmet medical need for effective treatments for CHD given potential limitations with existing treatment options.
To share your insights, please write to us at sudipto@intentamplify.com
